Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Research into antibiotic-resistant E. coli

Estimates reveal effect of chicken production on humans

Research has revealed that approximately 280 people die every year in the UK as a result of antibiotic-resistant E. coli, acquired from chicken.

The study, carried out by an international team of scientists, looked at the effect of using third-generation cephalosporin – a class of antibiotics – in chicken production.

It is known that the method is causing a rise the number of E. coli cases that are resistant to antibiotics, which is called extended-spectrum beta-lactamase (ESBL) E coli.

The team used Dutch genetic fingerprinting to find a reliable estimate of the number of human blood poisoning infections and deaths caused by ESBL E. coli that have come about as a result of consuming chicken.

They found that chicken production is, according to their analysis, responsible for 1,580 cases of ESBL E. coli blood poisoning every year in the UK.

Furthermore, it was revealed that
each year poultry-associated ESBL E. coli causes an additional 12,500 days in UK hospitals for "last-resort" antibiotic treatment.

"This is the first detailed estimate to emerge of the human-health consequences from the use of antibiotics in European agriculture," said Richard Young, policy adviser at the Soil Association.

"It indicated that large numbers of people die of resistant infections due to the over-reliance on antibiotics in intensive livestock farming."

He added that there are also major additional costs to the NHS from treating patients – even when they survive an ESBL E. coli infection.

Related News
Concerns over resistant E.coli superbugs
Antibiotics a key issue at G8

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'